Collectively, this study revealed the novel activity of Andro to suppress FATP2-mediated fatty acid import, which may act synergistically with reduced fatty acid synthesis and lipogenesis, resulting in attenuated hepatic steatosis. Here, SLC27A2 is linked to fatty liver disease.